Dyslipidemia and Point of Care Testing to Manage Cardiovascular Diseases Post Test

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

You must get at least 7/10 to pass.

First Name *

Last Name *

Email Address *

1. The CDC reported that in the United States that heart disease is the leading cause of death for most racial and ethnic groups *

1 point

True

False

2. Which of the following statements is a match for how atherosclerosis can affect any artery in the body? *

1 point

a. Peripheral arterial disease can result from plaque in the legs

b. Carotid artery disease is a result of plaque in the kidneys

c. Peripheral arterial disease is a result of plaque in the kidneys

d. Carotid artery disease is a result of plaque in the vasculature of the heart

3. The ACC/AHA guidelines have identified 4 major groups that would benefit from intensive statin therapy. Which of the following groups matches one of these recommendations? *

1 point

a. Patients with a diagnosis of diabetes mellitus Type I only

b. Patients with a past history of stroke

c. Patients with a sustained blood pressure elevation above 75 mmHg diastolic

d. Patients with an ASCVD risk calculated above 2%

4. JK is a 56-year old male with a history of diabetes. His LDL cholesterol is 140mg/dL. He takes aspirin every day as well as metformin. His HgA1c is 6.0%. His blood pressure is controlled with losartan and averages 120/80. He does not drink alcohol or smoke tobacco. Would the recommendation be that this patient be initiated on a high intensive statin therapy? *

1 point

True

False

5. SM is a 60-year old female with no history of any medical conditions and takes no other medications except a daily nonprescription multivitamin. Her pharmacist does a lipid screening point-of-care testing and puts the values in the ASCVD risk calculator, which included a LDL value of 120mg/dL. After the calculation the pharmacist sees that the patient’s predicted 10-year ASCVD risk is 7.4%. After reviewing the patient’s electronic chart from the cardiology clinic, she has a coronary artery calcium (CAC) score of 120. Would the recommendation be that this patient be provided intensive statin therapy? *

1 point

True

False

6. Which of the following statin drugs and dose is considered a high intensity statin? *

1 point

a. Fluvastatin 20mg

b. Lovastatin 20mg

c. Pravastatin 20mg

d. Rosuvastatin 20mg

7. When establishing a point of care testing program to screen for lipids, what would be the ideal age to recruit patients with at least one risk enhancing factor? *

1 point

a. Older than 20 years

b. Older than 35 years

c. Older than 45 years

d. Older than 50 years

8. Which one of the following is a risk enhancing factor to consider when developing a lipid point of care testing program? *

1 point

a. Chronic inflammatory disorder

b. History of pneumococcal pneumonia

c. Family history of type II diabetes mellitus

d. Family history of obesity

9. An advantage of using the CardioChek Plus machine over the Cholestech machine would be: *

1 point

a. CardioChek Plus is battery operated

b. CardioChek Plus is more accurate because it is CLIA waived

c. CardioChek Plus can be used for all ages including pediatrics

d. CardioChek Plus is a noninvasive infrared check without a finger stick

10. PK is a 59-year old male who has been treated with atorvastatin 80mg once daily for the last six months and has complied with all lifestyle modifications. An adherence check shows that he has only missed 3 doses in the last 6 months, which was confirmed by your pharmacy intern upon interviewing PK. Based on national lipid guidelines, the next drug to recommend to the prescriber would be? *

1 point

a. Rosuvastatin 10mg twice daily

b. Ezetimibe 10mg once daily

c. Alirocumab 75mg once every 2 weeks

d. Fish Oils 3 grams three times per day with meals

Submit

Clear form

Never submit passwords through Google Forms.

This form was created inside of Ohio Northern University. Report Abuse

Forms